Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of nebulized heparin for respiratory distress in COVID-19
IRCT20210513051275N1Phase 3Completed
- Sponsor
- Islamic Azad University
- Start
- Aug 2021
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of heparin in coronavirus disease 2019 (COVID-19), sponsored by Islamic Azad University. Started Aug 2021; status: completed.
02
Drugs
heparin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20210513051275N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210513051275N1.